- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Biologics and Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019.
Market segmentation
Biologics and Biosimilars market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Biologics and Biosimilars market has been segmented into Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other, etc.
Breakdown by Application, Biologics and Biosimilars has been segmented into Tumor, Diabetes, Cardiovascular, Hemophilia, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics and Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics and Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics and Biosimilars market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Biologics and Biosimilars Market Share Analysis
Biologics and Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Biologics and Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics and Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Biologics and Biosimilars are: Roche, Eli Lilly, Sanofi-Aventis, Amgen, Novo Nordisk, AbbVie, Merck, Pfizer, Johnson & Johnson, Novartis, Gelgen, Ganlee, 3sbio, Innovent, Biotech, Changchun High Tech, Dong Bao, CP Guojian, etc. Among other players domestic and global, Biologics and Biosimilars market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Biologics and Biosimilars market are listed below:
Roche
Eli Lilly
Sanofi-Aventis
Amgen
Novo Nordisk
AbbVie
Merck
Pfizer
Johnson & Johnson
Novartis
Gelgen
Ganlee
3sbio
Innovent
Biotech
Changchun High Tech
Dong Bao
CP Guojian
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market segment by Application, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologics and Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologics and Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Biologics and Biosimilars Market Size and Forecast (2015-2025)
1.4.1 Global Biologics and Biosimilars Revenue and Forecast (2015-2025)
1.4.2 Global Biologics and Biosimilars Sales and Forecast (2015-2025)
1.5 Global Biologics and Biosimilars Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis SWOT Analysis
2.3.4 Sanofi-Aventis Product and Services
2.3.5 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk SWOT Analysis
2.5.4 Novo Nordisk Product and Services
2.5.5 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Product and Services
2.6.4 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Product and Services
2.7.4 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Product and Services
2.9.4 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Product and Services
2.10.4 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Gelgen
2.11.1 Gelgen Details
2.11.2 Gelgen Major Business
2.11.3 Gelgen Product and Services
2.11.4 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ganlee
2.12.1 Ganlee Details
2.12.2 Ganlee Major Business
2.12.3 Ganlee Product and Services
2.12.4 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 3sbio
2.13.1 3sbio Details
2.13.2 3sbio Major Business
2.13.3 3sbio Product and Services
2.13.4 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Innovent
2.14.1 Innovent Details
2.14.2 Innovent Major Business
2.14.3 Innovent Product and Services
2.14.4 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biotech
2.15.1 Biotech Details
2.15.2 Biotech Major Business
2.15.3 Biotech Product and Services
2.15.4 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Changchun High Tech
2.16.1 Changchun High Tech Details
2.16.2 Changchun High Tech Major Business
2.16.3 Changchun High Tech Product and Services
2.16.4 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Dong Bao
2.17.1 Dong Bao Details
2.17.2 Dong Bao Major Business
2.17.3 Dong Bao Product and Services
2.17.4 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 CP Guojian
2.18.1 CP Guojian Details
2.18.2 CP Guojian Major Business
2.18.3 CP Guojian Product and Services
2.18.4 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Biologics and Biosimilars Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Biologics and Biosimilars Sales in United States (2018-2019)
3.2.2 United States Biologics and Biosimilars Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Biologics and Biosimilars Market Size by Geography (2015-2020)
4.1.1 Global Biologics and Biosimilars Sales by Geography (2015-2020)
4.1.2 Global Biologics and Biosimilars Revenue by Regions (2015-2020)
4.2 Global Biologics and Biosimilars Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Biologics and Biosimilars Sales and Forecast by Regions (2020-2025)
4.2.2 Global Biologics and Biosimilars Revenue and Forecast by Regions (2020-2025)
4.3 North America Biologics and Biosimilars Market Size and Forecast (2015-2025)
4.4 Europe Biologics and Biosimilars Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Biologics and Biosimilars Market Size and Forecast (2015-2025)
4.6 South America Biologics and Biosimilars Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Biologics and Biosimilars Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Biologics and Biosimilars Market Size by Country (2015-2020)
5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 North America Biologics and Biosimilars Market Size and Forecast by Country (2020-2025)
5.2.1 North America Biologics and Biosimilars Sales and Forecast by Country (2020-2025)
5.2.2 North America Biologics and Biosimilars Revenue and Forecast by Country (2020-2025)
5.3 United States Biologics and Biosimilars Market Size and Forecast (2015-2025)
5.4 Canada Biologics and Biosimilars Market Size and Forecast (2015-2025)
5.5 Mexico Biologics and Biosimilars Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Biologics and Biosimilars Market Size by Country (2015-2020)
6.1.1 Europe Biologics and Biosimilars Sales by Country (2015-2020)
6.1.2 Europe Biologics and Biosimilars Revenue by Country (2015-2020)
6.2 Europe Biologics and Biosimilars Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Biologics and Biosimilars Sales and Forecast by Country (2020-2025)
6.2.2 Europe Biologics and Biosimilars Revenue and Forecast by Country (2020-2025)
6.3 Germany Biologics and Biosimilars Market Size and Forecast (2015-2025)
6.4 United Kingdom Biologics and Biosimilars Market Size and Forecast (2015-2025)
6.5 France Biologics and Biosimilars Market Size and Forecast (2015-2025)
6.6 Russia Biologics and Biosimilars Market Size and Forecast (2015-2025)
6.7 Italy Biologics and Biosimilars Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biologics and Biosimilars Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Biologics and Biosimilars Sales by Region (2015-2020)
7.1.2 Asia-Pacific Biologics and Biosimilars Revenue by Region (2015-2020)
7.2 Asia-Pacific Biologics and Biosimilars Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Biologics and Biosimilars Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Biologics and Biosimilars Revenue and Forecast by Region (2020-2025)
7.3 China Biologics and Biosimilars Market Size and Forecast (2015-2025)
7.4 Japan Biologics and Biosimilars Market Size and Forecast (2015-2025)
7.5 Korea Biologics and Biosimilars Market Size and Forecast (2015-2025)
7.6 India Biologics and Biosimilars Market Size and Forecast (2015-2025)
7.7 Southeast Asia Biologics and Biosimilars Market Size and Forecast (2015-2025)
7.8 Australia Biologics and Biosimilars Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Biologics and Biosimilars Market Size by Country (2015-2020)
8.1.1 South America Biologics and Biosimilars Sales by Country (2015-2020)
8.1.2 South America Biologics and Biosimilars Revenue by Country (2015-2020)
8.2 South America Biologics and Biosimilars Market Size and Forecast by Country (2020-2025)
8.2.1 South America Biologics and Biosimilars Sales and Forecast by Country (2020-2025)
8.2.2 South America Biologics and Biosimilars Revenue and Forecast by Country (2020-2025)
8.3 Brazil Biologics and Biosimilars Market Size and Forecast (2015-2025)
8.4 Argentina Biologics and Biosimilars Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biologics and Biosimilars Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Biologics and Biosimilars Sales by Country (2015-2020)
9.1.2 Middle East & Africa Biologics and Biosimilars Revenue by Country (2015-2020)
9.2 Middle East & Africa Biologics and Biosimilars Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Biologics and Biosimilars Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Biologics and Biosimilars Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Biologics and Biosimilars Market Size and Forecast (2015-2025)
9.4 Turkey Biologics and Biosimilars Market Size and Forecast (2015-2025)
9.5 Egypt Biologics and Biosimilars Market Size and Forecast (2015-2025)
9.6 South Africa Biologics and Biosimilars Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Biologics and Biosimilars Market Size by Type (2015-2020)
10.1.1 Global Biologics and Biosimilars Sales by Type (2015-2020)
10.1.2 Global Biologics and Biosimilars Revenue by Type (2015-2020)
10.1.3 Global Biologics and Biosimilars Price by Type (2015-2020)
10.2 Global Biologics and Biosimilars Market Size and Forecast by Type (2020-2025)
10.2.1 Global Biologics and Biosimilars Sales and Forecast by Type (2020-2025)
10.2.2 Global Biologics and Biosimilars Revenue and Forecast by Type (2020-2025)
10.2.3 Global Biologics and Biosimilars Price and Forecast by Type (2020-2025)
10.3 United States Biologics and Biosimilars Market Size and Forecast by Type (2015-2025)
10.3.1 United States Biologics and Biosimilars Market Size by Type (2015-2020)
10.3.2 United States Biologics and Biosimilars Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Biologics and Biosimilars Market Size by Application (2015-2020)
11.1.1 Global Biologics and Biosimilars Sales by Application (2015-2020)
11.1.2 Global Biologics and Biosimilars Revenue by Application (2015-2020)
11.1.3 Global Biologics and Biosimilars Price by Application (2015-2020)
11.2 Global Biologics and Biosimilars Market Size and Forecast by Application (2020-2025)
11.2.1 Global Biologics and Biosimilars Sales and Forecast by Application (2020-2025)
11.2.2 Global Biologics and Biosimilars Revenue and Forecast by Application (2020-2025)
11.2.3 Global Biologics and Biosimilars Price and Forecast by Application (2020-2025)
11.3 United States Biologics and Biosimilars Market Size and Forecast by Application (2015-2025)
11.3.1 United States Biologics and Biosimilars Market Size by Application (2015-2020)
11.3.2 United States Biologics and Biosimilars Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Biologics and Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biologics and Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Biologics and Biosimilars Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Global Biologics and Biosimilars Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Roche Basic Information, Manufacturing Base and Competitors
Table 7. Roche Biologics and Biosimilars Major Business
Table 8. Roche Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 9. Roche SWOT Analysis
Table 10. Roche Biologics and Biosimilars Product and Services
Table 11. Roche Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 12. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 13. Eli Lilly Biologics and Biosimilars Major Business
Table 14. Eli Lilly Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 15. Eli Lilly SWOT Analysis
Table 16. Eli Lilly Biologics and Biosimilars Product and Services
Table 17. Eli Lilly Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 18. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi-Aventis Biologics and Biosimilars Major Business
Table 20. Sanofi-Aventis Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 21. Sanofi-Aventis SWOT Analysis
Table 22. Sanofi-Aventis Biologics and Biosimilars Product and Services
Table 23. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 24. Amgen Basic Information, Manufacturing Base and Competitors
Table 25. Amgen Biologics and Biosimilars Major Business
Table 26. Amgen Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 27. Amgen SWOT Analysis
Table 28. Amgen Biologics and Biosimilars Product and Services
Table 29. Amgen Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 30. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 31. Novo Nordisk Biologics and Biosimilars Major Business
Table 32. Novo Nordisk Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 33. Novo Nordisk SWOT Analysis
Table 34. Novo Nordisk Biologics and Biosimilars Product and Services
Table 35. Novo Nordisk Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 36. AbbVie Basic Information, Manufacturing Base and Competitors
Table 37. AbbVie Biologics and Biosimilars Major Business
Table 38. AbbVie Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 39. AbbVie SWOT Analysis
Table 40. AbbVie Biologics and Biosimilars Product and Services
Table 41. AbbVie Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 42. Merck Basic Information, Manufacturing Base and Competitors
Table 43. Merck Biologics and Biosimilars Major Business
Table 44. Merck Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 45. Merck SWOT Analysis
Table 46. Merck Biologics and Biosimilars Product and Services
Table 47. Merck Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 48. Pfizer Basic Information, Manufacturing Base and Competitors
Table 49. Pfizer Biologics and Biosimilars Major Business
Table 50. Pfizer Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 51. Pfizer SWOT Analysis
Table 52. Pfizer Biologics and Biosimilars Product and Services
Table 53. Pfizer Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 54. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 55. Johnson & Johnson Biologics and Biosimilars Major Business
Table 56. Johnson & Johnson Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 57. Johnson & Johnson SWOT Analysis
Table 58. Johnson & Johnson Biologics and Biosimilars Product and Services
Table 59. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 60. Novartis Basic Information, Manufacturing Base and Competitors
Table 61. Novartis Biologics and Biosimilars Major Business
Table 62. Novartis Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 63. Novartis SWOT Analysis
Table 64. Novartis Biologics and Biosimilars Product and Services
Table 65. Novartis Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 66. Gelgen Basic Information, Manufacturing Base and Competitors
Table 67. Gelgen Biologics and Biosimilars Major Business
Table 68. Gelgen Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 69. Gelgen SWOT Analysis
Table 70. Gelgen Biologics and Biosimilars Product and Services
Table 71. Gelgen Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 72. Ganlee Basic Information, Manufacturing Base and Competitors
Table 73. Ganlee Biologics and Biosimilars Major Business
Table 74. Ganlee Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 75. Ganlee SWOT Analysis
Table 76. Ganlee Biologics and Biosimilars Product and Services
Table 77. Ganlee Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 78. 3sbio Basic Information, Manufacturing Base and Competitors
Table 79. 3sbio Biologics and Biosimilars Major Business
Table 80. 3sbio Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 81. 3sbio SWOT Analysis
Table 82. 3sbio Biologics and Biosimilars Product and Services
Table 83. 3sbio Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 84. Innovent Basic Information, Manufacturing Base and Competitors
Table 85. Innovent Biologics and Biosimilars Major Business
Table 86. Innovent Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 87. Innovent SWOT Analysis
Table 88. Innovent Biologics and Biosimilars Product and Services
Table 89. Innovent Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 90. Biotech Basic Information, Manufacturing Base and Competitors
Table 91. Biotech Biologics and Biosimilars Major Business
Table 92. Biotech Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 93. Biotech SWOT Analysis
Table 94. Biotech Biologics and Biosimilars Product and Services
Table 95. Biotech Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 96. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 97. Changchun High Tech Biologics and Biosimilars Major Business
Table 98. Changchun High Tech Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 99. Changchun High Tech SWOT Analysis
Table 100. Changchun High Tech Biologics and Biosimilars Product and Services
Table 101. Changchun High Tech Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 102. Dong Bao Basic Information, Manufacturing Base and Competitors
Table 103. Dong Bao Biologics and Biosimilars Major Business
Table 104. Dong Bao Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 105. Dong Bao SWOT Analysis
Table 106. Dong Bao Biologics and Biosimilars Product and Services
Table 107. Dong Bao Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 108. CP Guojian Biologics and Biosimilars Type and Application
Table 109. CP Guojian Biologics and Biosimilars Major Business
Table 110. CP Guojian Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 111. CP Guojian SWOT Analysis
Table 112. CP Guojian Biologics and Biosimilars Product and Services
Table 113. CP Guojian Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 114. Global Biologics and Biosimilars Sales by Manufacturer (2018-2019) (K Units)
Table 115. Global Biologics and Biosimilars Revenue by Manufacturer (2018-2019) (USD Million)
Table 116. Key Players Biologics and Biosimilars Sales in United States (2018-2019) (K Units)
Table 117. Key Players Biologics and Biosimilars Sales Market Share in United States (2018-2019)
Table 118. Key Players Revenue of Biologics and Biosimilars in United States (2018-2019) (USD Million)
Table 119. Global Biologics and Biosimilars Sales by Regions (2015-2020) (K Units)
Table 120. Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 121. Global Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 122. Global Biologics and Biosimilars Sales and Forecast by Regions (2020-2025) (K Units)
Table 123. Global Biologics and Biosimilars Sales Market Share by Regions (2020-2025)
Table 124. Global Biologics and Biosimilars Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 125. Global Biologics and Biosimilars Revenue Market Share by Regions (2020-2025) (USD Million)
Table 126. North America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 127. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 128. North America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 129. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 130. North America Biologics and Biosimilars Sales by Country (2020-2025) (K Units)
Table 131. North America Biologics and Biosimilars Sales Market Share by Country (2020-2025)
Table 132. North America Biologics and Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 133. North America Biologics and Biosimilars Revenue Market Share by Country (2020-2025)
Table 134. Europe Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 135. Europe Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 136. Europe Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 137. Europe Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 138. Europe Biologics and Biosimilars Sales by Country (2020-2025) (K Units)
Table 139. Europe Biologics and Biosimilars Sales Market Share by Country (2020-2025)
Table 140. Europe Biologics and Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 141. Europe Biologics and Biosimilars Revenue Market Share by Country (2020-2025)
Table 142. Asia-Pacific Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 143. Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 144. Asia-Pacific Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 145. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 146. Asia-Pacific Biologics and Biosimilars Sales by Country (2020-2025) (K Units)
Table 147. Asia-Pacific Biologics and Biosimilars Sales Market Share by Country (2020-2025)
Table 148. Asia-Pacific Biologics and Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 149. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Country (2020-2025)
Table 150. South America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 151. South America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 152. South America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 153. South America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 154. South America Biologics and Biosimilars Sales by Country (2020-2025) (K Units)
Table 155. South America Biologics and Biosimilars Sales Market Share by Country (2020-2025)
Table 156. South America Biologics and Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 157. South America Biologics and Biosimilars Revenue Market Share by Country (2020-2025)
Table 158. Middle East & Africa Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 159. Middle East & Africa Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 160. Middle East & Africa Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 161. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 162. Middle East & Africa Biologics and Biosimilars Sales by Country (2020-2025) (K Units)
Table 163. Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2020-2025)
Table 164. Middle East & Africa Biologics and Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 165. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country (2020-2025)
Table 166. United States Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 167. United States Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 168. United States Biologics and Biosimilars Revenue by Type (2015-2020) (USD Million)
Table 169. United States Biologics and Biosimilars Revenue Market Share by Type (2015-2020)
Table 170. United States Biologics and Biosimilars Sales by Type (2020-2025) (K Units)
Table 171. United States Biologics and Biosimilars Sales Market Share by Type (2020-2025)
Table 172. United States Biologics and Biosimilars Revenue by Type (2020-2025) (USD Million)
Table 173. United States Biologics and Biosimilars Revenue Market Share by Type (2020-2025)
Table 174. Global Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 175. Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 176. Global Biologics and Biosimilars Revenue by Application (2015-2020) (USD Million)
Table 177. Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
Table 178. Global Biologics and Biosimilars Price by Application (2015-2020) (USD/Unit)
Table 179. Global Biologics and Biosimilars Sales by Application (2020-2025) (K Units)
Table 180. Global Biologics and Biosimilars Sales Market Share by Application (2020-2025)
Table 181. Global Biologics and Biosimilars Revenue by Application (2020-2025) (USD Million)
Table 182. Global Biologics and Biosimilars Revenue Market Share by Application (2020-2025)
Table 183. Global Biologics and Biosimilars Price by Application (2020-2025) (USD/Unit)
Table 184. United States Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 185. United States Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 186. United States Biologics and Biosimilars Revenue by Application (2015-2020) (USD Million)
Table 187. United States Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
Table 188. United States Biologics and Biosimilars Sales by Application (2020-2025) (K Units)
Table 189. United States Biologics and Biosimilars Sales Market Share by Application (2020-2025)
Table 190. United States Biologics and Biosimilars Revenue by Application (2020-2025) (USD Million)
Table 191. United States Biologics and Biosimilars Revenue Market Share by Application (2020-2025)
Table 192. Direct Channel Pros & Cons
Table 193. Indirect Channel Pros & Cons
Table 194. Distributors/Traders/ Dealers List
Table 195. Customers of Biologics and Biosimilars
Table 196. Market Opportunities in Next Few Years
Table 197. Market Risks Analysis
Table 198. Market Drivers
List of Figures
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Monoclonal Antibodies Picture
Figure 4. Interferon Picture
Figure 5. Erythropoietin Picture
Figure 6. Insulin Picture
Figure 7. Vaccines Picture
Figure 8. Other Picture
Figure 9. Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 10. Tumor Picture
Figure 11. Diabetes Picture
Figure 12. Cardiovascular Picture
Figure 13. Hemophilia Picture
Figure 14. Other Picture
Figure 15. Global Biologics and Biosimilars Market Status and Outlook (2015-2025) (USD Million)
Figure 16. Global Biologics and Biosimilars Sales Growth Rate (2015-2025) (K Units)
Figure 17. Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2019
Figure 18. Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2019
Figure 19. Key Players Biologics and Biosimilars Revenue Market Share in United States in 2019
Figure 20. Global Top 5 Biologics and Biosimilars Manufacturer Market Share in 2019
Figure 21. Top 3 Biologics and Biosimilars Players Market Share in United States in 2019
Figure 22. Global Biologics and Biosimilars Revenue Market Share by Regions in 2019
Figure 23. North America Biologics and Biosimilars Sales YoY Growth (2015-2025) (K Units)
Figure 24. North America Biologics and Biosimilars Revenue YoY Growth (2015-2025) (USD Million)
Figure 25. Europe Biologics and Biosimilars Sales YoY Growth (2015-2020) (K Units)
Figure 26. Europe Biologics and Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. Asia-Pacific Biologics and Biosimilars Sales YoY Growth (2015-2020) (K Units)
Figure 28. Asia-Pacific Biologics and Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 29. South America Biologics and Biosimilars Sales YoY Growth (2015-2020) (K Units)
Figure 30. South America Biologics and Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 31. Middle East & Africa Biologics and Biosimilars Sales YoY Growth (2015-2020) (K Units)
Figure 32. Middle East & Africa Biologics and Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 33. North America Biologics and Biosimilars Sales Market Share by Country in 2019
Figure 34. North America Biologics and Biosimilars Revenue Market Share by Country in 2019
Figure 35. United States Biologics and Biosimilars Market Size and Growth Rate (2015-2025) (USD Million)
Figure 36. Canada Biologics and Biosimilars Market Size and Growth Rate (2015-2025) (USD Million)
Figure 37. Mexico Biologics and Biosimilars Market Size and Growth Rate (2015-2020) (USD Million)
Figure 38. Europe Biologics and Biosimilars Revenue Market Share by Country in 2019
Figure 39. Germany Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. United Kingdom Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. France Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Russia Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Italy Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Asia-Pacific Biologics and Biosimilars Sales Market Share by Region 2018
Figure 45. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Region 2018
Figure 46. China Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Japan Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Korea Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. India Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Southeast Asia Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Australia Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. South America Biologics and Biosimilars Sales Market Share by Country in 2019
Figure 53. South America Biologics and Biosimilars Revenue Market Share by Country in 2019
Figure 54. Brazil Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Argentina Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Saudi Arabia Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Turkey Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 58. Egypt Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 59. South Africa Biologics and Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 60. Global Revenue Market Share of Biologics and Biosimilars by Type in 2019
Figure 61. Global Revenue Market Share of Biologics and Biosimilars by Application in 2019
Figure 62. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
